Kevin McCarthy, MD
Orthopaedic Surgery · Baton Rouge, LANPI 1407843501
Payments from drug & device makers
What this record shows
The money is spread across several categories — royalties or licence payments (59.7%), ownership interests and consulting fees — rather than concentrated in one kind of arrangement. 47 manufacturers reported payments, led by Precision Spine, Inc. at 38.4% of the total. Reporting peaked in 2019 at $190,029 and has fallen 79.5% since, to $38,887 in 2025. Among orthopaedic surgery clinicians in LA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 372 payments — averaging $1596.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Precision Spine, Inc.$228K
- Louisiana United Surgical Services, LLC$141K
- The Institute Of Musculoskeletal Science And Education$79K
- CTL Medical Corporation$75K
- Amendia, Inc.$25K
- Integrity Implants Inc.$16K
- plus $31K from 41 others
Across 14 payments — averaging $8600.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Providence Medical Technology, Inc.$100K
- Terumo BCT, Inc.$20K
What the payments were for
- Royalty or licence$354,25760%
- Consulting fees$55,9819%
- Travel & lodging$30,6905%
- Food & beverage$12,3572%
- Ownership interest$140,53824%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- REFORM POCT SYSTEM$132,551
- VAULT C ACDF SYSTEM$132,551
- Vault C$95,230
- Spira$46,670
- Reform Poct$32,632
- Spinal$32,126
- Medical Device$27,698
- Prolix$25,318
- MIS$17,983
- Mongoose$10,178
- Raphael Pedicle Screw System$9,119
- Orthros$7,335
- LATERAL ACCESS SPINAL SYSTEM$5,000
- FlareHawk$2,298
- RAVINE$1,380
- Intracept$1,003
- Ankle Fracture System$620
- PASS-LP$369
- NEW PRODUCT DEVELOPMENT$232
- SPINAL IMPLANT$224
How this compares
$593,823 in reported general payments places this provider in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Piroxicam | 54 | $29,846 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 1,184 | $15,468 |
| Hysingla ErHydrocodone Bitartrate | 12 | $8,115 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 491 | $7,209 |
| Calcipotriene | 21 | $6,684 |
| Xtampza ErOxycodone Myristate | 11 | $5,823 |
| Gabapentin | 311 | $4,783 |
| Methocarbamol | 329 | $2,582 |
| Oxycodone Hcl | 207 | $1,579 |
| Tramadol Hcl | 339 | $1,551 |
| Pregabalin | 133 | $1,427 |
| Cyclobenzaprine Hcl | 227 | $1,335 |
| Tizanidine Hcl | 164 | $1,119 |
| Butalbital-Acetaminophen-CaffeButalb/Acetaminophen/Caffeine | 28 | $696 |
| Meloxicam | 136 | $578 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er | $18 | $5,82311 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 286 orthopaedic surgery providers in Louisiana.
Other orthopaedic surgery in Baton Rouge
- Christopher HarrodBaton Rouge$3M
- Jorge IsazaBaton Rouge$1.2M
- Robert EastonBaton Rouge$394K
- Ricardo RodriguezBaton Rouge$262K
- Wame WaggenspackBaton Rouge$82K
- Shaun AccardoBaton Rouge$52K
- Kevin RicheBaton Rouge$33K
- William ShermanBaton Rouge$29K
- David FerachiBaton Rouge$16K
- Vinod DasaKenner$1.9M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.